To further evaluate the functional role of miR‐17 in GBM, we monitored the impact of either XBP1 silencing or antagonizing miR‐17 in U87 or U251 cells expressing an empty vector or the IRE1 A414T variant. Here, XBP1 is linked to glioblastoma.